
样式: 排序: IF: - GO 导出 标记为已读
-
AI image generation technology in ophthalmology: Use, misuse and future applications Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2025-03-17 Benjamin Phipps, Xavier Hadoux, Bin Sheng, J. Peter Campbell, T.Y. Alvin Liu, Pearse A. Keane, Carol Y. Cheung, Tham Yih Chung, Tien Y. Wong, Peter van Wijngaarden
AI-powered image generation technology holds the potential to reshape medical practice, yet it remains an unfamiliar technology for both medical researchers and clinicians alike. Given the adoption of this technology relies on clinician understanding and acceptance, we sought to demystify its use in ophthalmology. To this end, we present a literature review on image generation technology in ophthalmology
-
Gene Therapy-Associated Uveitis (GTAU): Understanding and mitigating the adverse immune response in retinal gene therapy Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2025-03-14 Ryan Purdy, Molly John, Alissa Bray, Alison J. Clare, David A. Copland, Ying Kai Chan, Robert H. Henderson, Fanny Nerinckx, Bart P. Leroy, Paul Yang, Mark E. Pennesi, Robert E. MacLaren, M Dominik Fischer, Andrew D. Dick, Kanmin Xue
Retinal gene therapy using adeno-associated viral (AAV) vectors has been a groundbreaking step-change in the treatment of inherited retinal diseases (IRDs) and could also be used to treat more common retinal diseases such as age-related macular degeneration and diabetic retinopathy. The delivery and expression of therapeutic transgenes in the eye is limited by innate and adaptive immune responses against
-
AI explainability in oculomics: How it works, its role in establishing trust, and what still needs to be addressed Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2025-03-12 Songyang An, Kelvin Teo, Michael V. McConnell, John Marshall, Christopher Galloway, David Squirrell
Recent developments in artificial intelligence (AI) have seen a proliferation of algorithms that are now capable of predicting a range of systemic diseases from retinal images. Unlike traditional retinal disease detection AI models which are trained on well-recognised retinal biomarkers, systemic disease detection or “oculomics” models use a range of often poorly characterised retinal biomarkers to
-
En face OCT: Breakthroughs in understanding the pathoanatomy of retinal disease and clinical applications Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2025-03-05 Alessandro Feo, Prithvi Ramtohul, Andrea Govetto, Enrico Borrelli, Riccardo Sacconi, Giulia Corradetti, Giuseppe Querques, Mario R. Romano, Philip J. Rosenfeld, Richard F. Spaide, K Bailey Freund, SriniVas Sadda, David Sarraf
En face optical coherence tomography (OCT) is a practical and informative imaging modality to noninvasively visualize distinct retinal and choroidal layers by providing coronal images using boundary-specific segmentation. Ongoing research with this method is generating breakthroughs in the illustration of new perspectives of retinal disease. The clinical value of en face OCT as an advanced retinal
-
Oculomics: Current concepts and evidence Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2025-03-04 Zhuoting Zhu, Yueye Wang, Ziyi Qi, Wenyi Hu, Xiayin Zhang, Siegfried K. Wagner, Yujie Wang, An Ran Ran, Joshua Ong, Ethan Waisberg, Mouayad Masalkhi, Alex Suh, Yih Chung Tham, Carol Y. Cheung, Xiaohong Yang, Honghua Yu, Zongyuan Ge, Wei Wang, Bin Sheng, Yun Liu, Andrew G. Lee, Alastair K. Denniston, Peter van Wijngaarden, Pearse A. Keane, Ching-Yu Cheng, Mingguang He, Tien Yin Wong
The eye provides novel insights into general health, as well as pathogenesis and development of systemic diseases. In the past decade, growing evidence has demonstrated that the eye's structure and function mirror multiple systemic health conditions, especially in cardiovascular diseases, neurodegenerative disorders, and kidney impairments. This has given rise to the field of oculomics-the application
-
Microglial regulation of the retinal vasculature in health and during the pathology associated with diabetes Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2025-02-26 Andrew I. Jobling, Ursula Greferath, Michael A. Dixon, Pialuisa Quiriconi, Belinda Eyar, Anna K. van Koeverden, Samuel A. Mills, Kirstan A. Vessey, Bang V. Bui, Erica L. Fletcher
The high metabolic demand of retinal neurons requires a precisely regulated vascular system that can deliver rapid changes in blood flow in response to neural need. In the retina, this is achieved via the action of a coordinated group of cells that form the neurovascular unit. While cells such as pericytes, Müller cells, and astrocytes have long been linked to neurovascular coupling, more recently
-
Spaceflight Associated Neuro-ocular Syndrome (SANS) and its countermeasures Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2025-02-17 Tuan Nguyen, Joshua Ong, Tyson Brunstetter, C. Robert Gibson, Brandon R. Macias, Steven Laurie, Thomas Mader, Alan Hargens, Jay C. Buckey, Mimi Lan, Peter Wostyn, Cihan Kadipasaoglu, Scott M. Smith, Sara R. Zwart, Benjamin J. Frankfort, Sarah Aman, Jessica M. Scott, Ethan Waisberg, Mouayad Masalkhi, Andrew G. Lee
Astronauts can develop a distinct collection of neuro-ophthalmic findings during long duration spaceflight, collectively known as Spaceflight Associated Neuro-ocular Syndrome (SANS). These clinical characteristics include optic disc edema, hyperopic refractive shifts, globe flattening, and chorioretinal folds, which may pose a health risk for future space exploration. Obtaining knowledge of SANS and
-
The dark and bright sides of retinal G protein-coupled receptor (RGR) in vision and disease Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2025-02-15 Grace Ruddin, Tess McCann, John D. Fehilly, Jodie Kearney, Breandán N. Kennedy
The visual chromophore 11-cis-retinal (11cRAL) is essential to vertebrate phototransduction and therefore, must be regenerated so vision can be sustained. 11cRAL regeneration mediated by the classical visual cycle is insufficient under photopic conditions. Expressed in the retinal pigment epithelium (RPE) and Müller glia, the retinal G protein-coupled receptor (RGR) can act as an alternative visual
-
A comprehensive scoping review of methodological approaches and clinical applications of tear fluid biomarkers Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2025-02-13 Marlies Gijs, Nienke van de Sande, Clémence Bonnet, Jente Schmeetz, Rosa Fernandes, Sònia Travé-Huarte, Marcela Huertas-Bello, Jeremy Chung Bo Chiang, Nikolay Boychev, Shruti Sharma, the Tear Research Network Scoping Review taskforce, Françoise Brignole-Baudouin, Karima Kessal, Paul Lingor, Maurice M.T.H. Heunen, Xiangjun Chen, Ananya Datta, Li Liang, Carlos Cifuentes-González, William Rojas-Carabali
Tear fluid is an emerging source of disease biomarkers, drawing attention due to its quick, inexpensive, and non-invasive collection. The advancements in detection techniques enable the measurement of ultra-low biomarker levels from small sample volumes typical of tear fluid. The lack of standardized protocols for collection, processing, and analysis of tear fluid remains a significant challenge. To
-
Prosthetic eye care – The current state of the art Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2025-02-10 Alexander C. Rokohl, Keith R. Pine, Nicola S. Pine, Erik Gordon, Janice Yeoman, Jelmer S. Remmers, Dyonne T. Hartong, Ludwig M. Heindl
After eye loss, a fast supply with a visually appealing prosthetic eye is not just a cosmetic solution, it is the key factor for a successful social, occupational, and psychological rehabilitation. For a long time, prosthetic eye care was based on acquired experiences, and there was a significant lack of systematic studies and peer-reviewed literature on this subject. However, in recent decades, research
-
Comparative insights into the role of sex hormones in glaucoma among women and men Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2025-01-31 Sharon H. Zhao, Christine K. Kim, Tala Al-Khaled, Margaret Ann Chervinko, Anne Wishna, Rukhsana G. Mirza, Thasarat Sutabutr Vajaranant
Baseline differences in sex hormone levels between males and females influence tissues including the brain and eye. To investigate the effects of estrogens and androgens on ocular physiology and glaucoma, we review the current literature on the influence of primary sex hormones on ocular function, glaucoma incidence and related parameters like intraocular pressure (IOP) at physiologic levels and related
-
RNA methylation homeostasis in ocular diseases: All eyes on Me Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2025-01-27 Jieling Tang, Chuandi Zhou, Fuxiang Ye, Sipeng Zuo, Min Zhou, Linna Lu, Peiwei Chai, Xianqun Fan
RNA methylation is a pivotal epigenetic modification that adjusts various aspects of RNA biology, including nuclear transport, stability, and the efficiency of translation for specific RNA candidates. The methylation of RNA involves the addition of methyl groups to specific bases and can occur at different sites, resulting in distinct forms, such as N6-methyladenosine (m6A), N1-methyladenosine (m1A)
-
Exploring retinal conditions through blue light reflectance imaging Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2025-01-03 Ricardo Luz Leitão Guerra, Cezar Luz Leitão Guerra, Mariana Gouveia Bastos Meirelles, Gabriel Castilho Sandoval Barbosa, Eduardo Amorim Novais, Emmerson Badaró, Luiz Filipe Adami Lucatto, Luiz Roisman
Blue light reflectance (BLR) imaging offers a non-invasive, cost-effective method for evaluating retinal structures by analyzing the reflectance and absorption characteristics of the inner retinal layers. By leveraging blue light's interaction with retinal tissues, BLR enhances visualization beyond the retinal nerve fiber layer, improving detection of structures such as the outer plexiform layer and
-
Unraveling ptosis: A comprehensive review of clinical manifestations, genetics, and treatment Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-12-24 Hao Deng, Qianling Zhang, Junhui Yi, Lamei Yuan
Ptosis is defined as an abnormally low-lying upper eyelid margin on the primary gaze, generally resulting from a congenital or acquired abnormality of the nerves or muscles that control the eyelid. Ptosis can occur alone or concurrently as an ocular or systemic syndrome, and the prevalence of ptosis varies among different countries and populations. Isolated ptosis typically causes aesthetic problems
-
Healing the cornea: Exploring the therapeutic solutions offered by MSCs and MSC-derived EVs Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-12-20 Manon Jammes, Abbas Tabasi, Trung Bach, Thomas Ritter
Affecting a large proportion of the population worldwide, corneal disorders constitute a concerning health hazard associated to compromised eyesight or blindness for most severe cases. In the last decades, mesenchymal stem/stromal cells (MSCs) demonstrated promising abilities in improving symptoms associated to corneal diseases or alleviating these affections, especially through their anti-inflammatory
-
Corneal cross-linking Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-12-15 Farhad Hafezi, Sabine Kling, Nikki L. Hafezi, M. Enes Aydemir, Nan-Ji Lu, Mark Hillen, Boris Knyazer, Shady Awwad, Cosimo Mazzotta, Léonard Kollros, Emilio A. Torres-Netto
First introduced over 20 years ago as a treatment for progressive keratoconus, the original “Dresden” corneal cross-linking (CXL) protocol involved riboflavin saturation of the stroma, followed by 30 min of 3 mW/cm2-intensity ultraviolet-A (UV-A) irradiation. This procedure generates reactive oxygen species (ROS) that cross-link stromal molecules, thereby stiffening the cornea and counteracting the
-
Multiple gene therapy as a tool for regulating the expression of molecules involved in neovascular age-related macular degeneration Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-12-11 Thomas J. Corydon, Toke Bek
Anti-vascular endothelial growth factor (VEGF) therapies have revolutionized the treatment of neovascular age-related macular degeneration (nAMD) and other retinal diseases. However, the necessity for repeated intravitreal injections and the observation of variable treatment responses calls for new treatment modalities where fewer and more effective interventions can result in a clinical effect. Gene
-
Corrigendum to “Optical coherence tomography in the management of diabetic macular oedema” [Prog. Retin. Eye Res. 98 (2024) 101220] Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-11-30 Simon KH. Szeto, Timothy YY. Lai, Stela Vujosevic, Jennifer K. Suns, SriniVas R. Sadda, Gavin Tan, Sobha Sivaprasad, Tien Y. Wong, Carol Y. Cheung
-
pH in the vertebrate retina and its naturally occurring and pathological changes Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-11-26 Andrey V. Dmitriev, Robert A. Linsenmeier
This review summarizes the existing information on the concentration of H+ (pH) in vertebrate retinae and its changes due to various reasons. Special features of H+ homeostasis that make it different from other ions will be discussed, particularly metabolic production of H+ and buffering. The transretinal distribution of extracellular H+ concentration ([H+]o) and its changes under illumination and
-
Extensive macular atrophy with pseudodrusen-like appearance (EMAP) clinical characteristics, diagnostic criteria, and insights from allied inherited retinal diseases and age-related macular degeneration Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-11-25 Alessio Antropoli, Lorenzo Bianco, Francesco Romano, Andrea Trinco, Alessandro Arrigo, Amine Benadji, Raphaël Atia, Oana Palacci, Dorothée Dagostinoz, Céline Devisme, Christel Condroyer, Aline Antonio, Francesca Bosello, Stefano Casati, Anna Paola Salvetti, Chiara Zaffalon, Alain Gaudric, José-Alain Sahel, Giovanni Staurenghi, Francesco Bandello, Florian Sennlaub, Christina Zeitz, Isabelle Meunier
Extensive macular atrophy with pseudodrusen-like appearance (EMAP) was first described in France in 2009 as a symmetric and rapidly progressive form of macular atrophy primarily affecting middle-aged individuals. Despite the recent identification of a significant number of cases in Italy and worldwide, EMAP remains an underrecognized condition. The clinical triad typical of EMAP consists of vertically
-
Cellular component transfer between photoreceptor cells of the retina Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-11-16 Joyce Wang, Patrick O. Nnoromele, Ying V. Liu, Robert J. Johnston Jr., Mandeep S. Singh
Photoreceptor transplantation is a potential therapeutic strategy for degenerative retinal diseases. Studies on mechanisms contributing to retinal regeneration and vision repair identified cellular components transfer (CCT) as playing a role, in addition to somatic augmentation (referred to as “cell replacement” in this paper). In CCT, donor photoreceptors shuttle proteins, RNA, and mitochondria to
-
Role of epigenetics in corneal health and disease Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-11-14 Swati Sood, Anil Tiwari, Jyoti Sangwan, Mehak Vohra, Nishant R. Sinha, Ratnakar Tripathi, Virender S. Sangwan, Rajiv R. Mohan
Epigenetics plays a vital role in corneal health and diseases. Epigenetic changes regulate the expression of genes by altering the accessibility of chromatin via histone modifications, DNA methylation and miRNAs without altering DNA sequence. Ocular trauma and infections are common causes of corneal damage, vision impairment, and mono/bilateral blindness worldwide. Mounting literature shows that epigenetic
-
Dual inheritance patterns: A spectrum of non-syndromic inherited retinal disease phenotypes with varying molecular mechanisms Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-10-31 Lara K. Holtes, Suzanne E. de Bruijn, Frans P.M. Cremers, Susanne Roosing
Inherited retinal diseases (IRDs) encompass a variety of disease phenotypes and are known to display both clinical and genetic heterogeneity. A further complexity is that for several IRD-associated genes, pathogenic variants have been reported to cause either autosomal dominant (AD) or autosomal recessive (AR) diseases. The possibility of dual inheritance can create a challenge for variant interpretation
-
Eye on the horizon: The metabolic landscape of the RPE in aging and disease Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-10-19 David S. Hansman, Jianhai Du, Robert J. Casson, Daniel J. Peet
To meet the prodigious bioenergetic demands of the photoreceptors, glucose and other nutrients must traverse the retinal pigment epithelium (RPE), a polarised monolayer of cells that lie at the interface between the outer retina and the choroid, the principal vascular layer of the eye. Recent investigations have revealed a metabolic ecosystem in the outer retina where the photoreceptors and RPE engage
-
Standard automated perimetry for glaucoma and diseases of the retina and visual pathways: Current and future perspectives Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-10-15 Jack Phu, Sieu K. Khuu, Lisa Nivison-Smith, Michael Kalloniatis
Static automated perimetry (SAP) remains a mainstay of functional assessment of the visual field in diseases of the visual pathway, such as glaucoma and age-related macular degeneration. The fundamental psychophysical task of responding to stimuli of different levels of contrast has remained minimally changed since its inception in the 1980s, and this is potentially the root of several unresolved issues
-
Pathobiology of the crystalline lens in Stickler syndrome Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-09-29 Martin P. Snead, Frank J. Lovicu, Thomas RW. Nixon, Allan J. Richards, Howard Martin
The Stickler syndromes are a group of connective tissue disorders characterised by congenital myopia, giant retinal tear and retinal detachment, cleft palate, hearing loss and premature arthropathy. Patients with Stickler syndrome are also susceptible to abnormalities of the crystalline lens. Since neither type II or type XI collagen (those typically affected in the vast majority of Stickler patients)
-
AI in the clinical management of GA: A novel therapeutic universe requires novel tools Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-09-27 Gregor S. Reiter, Julia Mai, Sophie Riedl, Klaudia Birner, Sophie Frank, Hrvoje Bogunovic, Ursula Schmidt-Erfurth
Regulatory approval of the first two therapeutic substances for the management of geographic atrophy (GA) secondary to age-related macular degeneration (AMD) is a major breakthrough following failure of numerous previous trials. However, in the absence of therapeutic standards, diagnostic tools are a key challenge as functional parameters in GA are hard to provide. The majority of anatomical biomarkers
-
The relationship between intraocular pressure and glaucoma: An evolving concept Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-09-19 Sanjay G. Asrani, Elyse J. McGlumphy, Lama A. Al-Aswad, Craig J. Chaya, Shan Lin, David C. Musch, Ian Pitha, Alan L. Robin, Barbara Wirostko, Thomas V. Johnson
Intraocular pressure (IOP) is the most important modifiable risk factor for glaucoma and fluctuates considerably within patients over short and long time periods. Our field's understanding of IOP has evolved considerably in recent years, driven by tonometric technologies with increasing accuracy, reproducibility, and temporal resolution that have refined our knowledge regarding the relationship between
-
Ocular adverse events associated with antibody-drug conjugates used in cancer: Focus on pathophysiology and management strategies Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-09-18 Eric E. Gabison, Antoine Rousseau, Marc Labetoulle, Anas Gazzah, Benjamin Besse
Antibody-drug conjugates (ADCs) are designed to maximize cancer cell death with lower cytotoxicity toward noncancerous cells and are an increasingly valuable option for targeted cancer therapies. However, anticancer treatment with ADCs may be associated with ocular adverse events (AEs) such as dry eye, conjunctivitis, photophobia, blurred vision, and corneal abnormalities. While the pathophysiology
-
The role of CFTR in the eye, and the effect of early highly effective modulator treatment for cystic fibrosis on eye health Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-09-06 Elena K. Schneider-Futschik, Yimin Zhu, Danni Li, Mark D. Habgood, Bao N. Nguyen, Ines Pankonien, Margarida D. Amaral, Laura E. Downie, Holly R. Chinnery
Cystic fibrosis transmembrane conductance regulator (CFTR) is a protein that plays a crucial role in various human organs, including the respiratory and digestive systems. Dysfunctional CFTR is the key variant of the lethal genetic disorder, cystic fibrosis (CF). In the past decade, highly effective CFTR modulator therapies, including elexacaftor-tezacaftor-ivacaftor, have revolutionised CF management
-
Optical coherence tomography angiography of the retina and choroid in systemic diseases Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-08-30 Jacqueline Chua, Bingyao Tan, Damon Wong, Gerhard Garhöfer, Xin Wei Liew, Alina Popa-Cherecheanu, Calvin Woon Loong Chin, Dan Milea, Christopher Li-Hsian Chen, Leopold Schmetterer
Optical coherence tomography angiography (OCTA) has transformed ocular vascular imaging, revealing microvascular changes linked to various systemic diseases. This review explores its applications in diabetes, hypertension, cardiovascular diseases, and neurodegenerative diseases. While OCTA provides a valuable window into the body's microvasculature, interpreting the findings can be complex. Additionally
-
The AI revolution in glaucoma: Bridging challenges with opportunities Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-08-24 Fei Li, Deming Wang, Zefeng Yang, Yinhang Zhang, Jiaxuan Jiang, Xiaoyi Liu, Kangjie Kong, Fengqi Zhou, Clement C. Tham, Felipe Medeiros, Ying Han, Andrzej Grzybowski, Linda M. Zangwill, Dennis S.C. Lam, Xiulan Zhang
Recent advancements in artificial intelligence (AI) herald transformative potentials for reshaping glaucoma clinical management, improving screening efficacy, sharpening diagnosis precision, and refining the detection of disease progression. However, incorporating AI into healthcare usages faces significant hurdles in terms of developing algorithms and putting them into practice. When creating algorithms
-
Value proposition of retinal imaging in Alzheimer's disease screening: A review of eight evolving trends Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-08-22 Victor T.T. Chan, An Ran Ran, Siegfried K. Wagner, Herbert Y.H. Hui, Xiaoyan Hu, Ho Ko, Sharon Fekrat, Yaxing Wang, Cecilia S. Lee, Alvin L. Young, Clement C. Tham, Yih Chung Tham, Pearse A. Keane, Dan Milea, Christopher Chen, Tien Yin Wong, Vincent C.T. Mok, Carol Y. Cheung
Alzheimer's disease (AD) is the leading cause of dementia worldwide. Current diagnostic modalities of AD generally focus on detecting the presence of amyloid β and tau protein in the brain (for example, positron emission tomography [PET] and cerebrospinal fluid testing), but these are limited by their high cost, invasiveness, and lack of expertise. Retinal imaging exhibits potential in AD screening
-
Genetic therapies and potential therapeutic applications of CRISPR activators in the eye Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-08-08 Benjamin WJ. Ng, Maria K. Kaukonen, Michelle E. McClements, Hoda Shamsnajafabadi, Robert E. MacLaren, Jasmina Cehajic-Kapetanovic
Conventional gene therapy involving supplementation only treats loss-of-function diseases and is limited by viral packaging sizes, precluding therapy of large genes. The discovery of CRISPR/Cas has led to a paradigm shift in the field of genetic therapy, with the promise of precise gene editing, thus broadening the range of diseases that can be treated. The initial uses of CRISPR/Cas have focused mainly
-
Congenital anterior segment ocular disorders: Genotype-phenotype correlations and emerging novel mechanisms Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-08-02 Linda M. Reis, Sarah E. Seese, Deborah Costakos, Elena V. Semina
Development of the anterior segment of the eye requires reciprocal sequential interactions between the arising tissues, facilitated by numerous genetic factors. Disruption of any of these processes results in congenital anomalies in the affected tissue(s) leading to anterior segment disorders (ASD) including aniridia, Axenfeld-Rieger anomaly, congenital corneal opacities (Peters anomaly, cornea plana
-
In vitro and ex vivo models of microbial keratitis: Present and future Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-07-14 Kelvin Kah Wai Cheng, Leonie Fingerhut, Sheelagh Duncan, N. Venkatesh Prajna, Adriano G. Rossi, Bethany Mills
Microbial keratitis (MK) is an infection of the cornea, caused by bacteria, fungi, parasites, or viruses. MK leads to significant morbidity, being the fifth leading cause of blindness worldwide. There is an urgent requirement to better understand pathogenesis in order to develop novel diagnostic and therapeutic approaches to improve patient outcomes. Many and MK models have been developed and implemented
-
Exploring single-cell RNA sequencing as a decision-making tool in the clinical management of Fuchs’ endothelial corneal dystrophy Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-07-03 Gink N. Yang, Yu B.Y. Sun, Philip Ke Roberts, Hothri Moka, Min K. Sung, Jesse Gardner-Russell, Layal El Wazan, Bridget Toussaint, Satheesh Kumar, Heather Machin, Gregory J. Dusting, Geraint J. Parfitt, Kathryn Davidson, Elaine W. Chong, Karl D. Brown, Jose M. Polo, Mark Daniell
Single-cell RNA sequencing (scRNA-seq) has enabled the identification of novel gene signatures and cell heterogeneity in numerous tissues and diseases. Here we review the use of this technology for Fuchs’ Endothelial Corneal Dystrophy (FECD). FECD is the most common indication for corneal endothelial transplantation worldwide. FECD is challenging to manage because it is genetically heterogenous, can
-
Ocular manifestations of COVID-19 Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-06-24 Hannah W. Ng, Daniel A.R. Scott, Helen V. Danesh-Meyer, Justine R. Smith, Charles NJ. McGhee, Rachael L. Niederer
There is an increasing body of knowledge regarding how COVID-19 may be associated with ocular disease of varying severity and duration. This article discusses the literature on the ocular manifestations associated with COVID-19, including appraisal of the current evidence, suggested mechanisms of action, associated comorbidities and risk factors, timing from initial infection to diagnosis and clinical
-
Crosslinking with UV-A and riboflavin in progressive keratoconus: From laboratory to clinical practice – Developments over 25 years Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-06-01 Frederik Raiskup, Robert Herber, Janine Lenk, Lutz E. Pillunat, Eberhard Spoerl
Changes in the biomechanical and biochemical properties of the human cornea play an important role in the pathogenesis of ectatic diseases. A number of conditions in primarily acquired (keratoconus or pellucid marginal degeneration) or secondarily induced (iatrogenic keratectasia after refractive laser surgeries) ectatic disorders lead to decreased biomechanical stability. Corneal collagen cross-linking
-
Pseudoxanthoma elasticum – Genetics, pathophysiology, and clinical presentation Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-05-28 Kristina Pfau, Imre Lengyel, Jeannette Ossewaarde-van Norel, Redmer van Leeuwen, Sara Risseeuw, Georges Leftheriotis, Hendrik P.N. Scholl, Nicolas Feltgen, Frank G. Holz, Maximilian Pfau
Pseudoxanthoma elasticum (PXE) is an autosomal-recessively inherited multisystem disease. Mutations in the -gene are causative, coding for a transmembrane transporter mainly expressed in hepatocytes, which promotes the efflux of adenosine triphosphate (ATP). This results in low levels of plasma inorganic pyrophosphate (PPi), a critical anti-mineralization factor. The clinical phenotype of PXE is characterized
-
Cell therapy in the cornea: The emerging role of microenvironment Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-05-24 Giuseppe Suanno, Vincenzo Giuseppe Genna, Eleonora Maurizi, Anas Abu Dieh, May Griffith, Giulio Ferrari
-
Chromatic visual evoked potentials: A review of physiology, methods and clinical applications Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-05-16 Oliver R. Marmoy, Manca Tekavčič Pompe, Jan Kremers
Objective assessment of the visual system can be performed electrophysiologically using the visual evoked potential (VEP). In many clinical circumstances, this is performed using high contrast achromatic patterns or diffuse flash stimuli. These methods are clinically valuable but they may only assess a subset of possible physiological circuitries within the visual system, particularly those involved
-
Alzheimer's disease pathophysiology in the Retina Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-05-15 Bhakta Prasad Gaire, Yosef Koronyo, Dieu-Trang Fuchs, Haoshen Shi, Altan Rentsendorj, Ron Danziger, Jean-Philippe Vit, Nazanin Mirzaei, Jonah Doustar, Julia Sheyn, Harald Hampel, Andrea Vergallo, Miyah R. Davis, Ousman Jallow, Filippo Baldacci, Steven R. Verdooner, Ernesto Barron, Mehdi Mirzaei, Vivek K. Gupta, Stuart L. Graham, Mourad Tayebi, Roxana O. Carare, Alfredo A. Sadun, Carol A. Miller, Oana
The retina is an emerging CNS target for potential noninvasive diagnosis and tracking of Alzheimer's disease (AD). Studies have identified the pathological hallmarks of AD, including amyloid β-protein (Aβ) deposits and abnormal tau protein isoforms, in the retinas of AD patients and animal models. Moreover, structural and functional vascular abnormalities such as reduced blood flow, vascular Aβ deposition
-
Resilience to diabetic retinopathy Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-05-11 Anara Serikbaeva, Yanliang Li, Simon Ma, Darvin Yi, Andrius Kazlauskas
Chronic elevation of blood glucose at first causes relatively minor changes to the neural and vascular components of the retina. As the duration of hyperglycemia persists, the nature and extent of damage increases and becomes readily detectable. While this second, overt manifestation of diabetic retinopathy (DR) has been studied extensively, what prevents maximal damage from the very start of hyperglycemia
-
Mitochondrial retinopathies and optic neuropathies: The impact of retinal imaging on modern understanding of pathogenesis, diagnosis, and management Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-05-03 Enrico Borrelli, Francesco Bandello, Camiel J.F. Boon, Valerio Carelli, Guy Lenaers, Michele Reibaldi, Srinivas R. Sadda, Alfredo A. Sadun, David Sarraf, Patrick Yu-Wai-Man, Piero Barboni
Advancements in ocular imaging have significantly broadened our comprehension of mitochondrial retinopathies and optic neuropathies by examining the structural and pathological aspects of the retina and optic nerve in these conditions. This article aims to review the prominent imaging characteristics associated with mitochondrial retinopathies and optic neuropathies, aiming to deepen our insight into
-
Targeting inflammasomes and pyroptosis in retinal diseases—molecular mechanisms and future perspectives Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-04-23 Yimeng Sun, Fan Li, Yunfei Liu, Dijie Qiao, Xinyu Yao, Guei-Sheung Liu, Dequan Li, Chuanle Xiao, Tao Wang, Wei Chi
Retinal diseases encompass various conditions associated with sight-threatening immune responses and are leading causes of blindness worldwide. These diseases include age-related macular degeneration, diabetic retinopathy, glaucoma and uveitis. Emerging evidence underscores the vital role of the innate immune response in retinal diseases, beyond the previously emphasized T-cell-driven processes of
-
Toward an internationally accepted standard for reading charts Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-04-02 Wolfgang Radner
Patients who suffer from sight-threatening eye diseases share a desire to regain a comfortable reading ability. In light of the modern advances achieved in ophthalmic diagnosis and therapy, and because a significant lack of comparability between reading charts still exists, there is an increasing need for a worldwide standard in the form of a norm for diagnostic reading charts. Already, applied advancements
-
Addressing neurodegeneration in glaucoma: Mechanisms, challenges, and treatments Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-03-26 Ghazi O. Bou Ghanem, Lauren K. Wareham, David J. Calkins
Glaucoma is the leading cause of irreversible blindness globally. The disease causes vision loss due to neurodegeneration of the retinal ganglion cell (RGC) projection to the brain through the optic nerve. Glaucoma is associated with sensitivity to intraocular pressure (IOP). Thus, mainstay treatments seek to manage IOP, though many patients continue to lose vision. To address neurodegeneration directly
-
Glycative stress as a cause of macular degeneration Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-03-21 Eloy Bejarano, Alicia Domenech-Bendaña, Norma Avila-Portillo, Sheldon Rowan, Sachini Edirisinghe, Allen Taylor
People are living longer and rates of age-related diseases such as age-related macular degeneration (AMD) are accelerating, placing enormous burdens on patients and health care systems. The quality of carbohydrate foods consumed by an individual impacts health The glycemic index (GI) is a kinetic measure of the rate at which glucose arrives in the blood stream after consuming various carbohydrates
-
How gut microbiota may impact ocular surface homeostasis and related disorders Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-03-08 Marc Labetoulle, Christophe Baudouin, Jose M. Benitez del Castillo, Maurizio Rolando, Maria Rescigno, Elisabeth M. Messmer, Pasquale Aragona
Changes in the bacterial flora in the gut, also described as gut microbiota, are readily acknowledged to be associated with several systemic diseases, especially those with an inflammatory, neuronal, psychological or hormonal factor involved in the pathogenesis and/or the perception of the disease. Maintaining ocular surface homeostasis is also based on all these four factors, and there is accumulating
-
Translocator protein (18 kDa) (Tspo) in the retina and implications for ocular diseases Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-03-01 Mandy Hector, Thomas Langmann, Anne Wolf
Translocator protein (18 kDa) (Tspo), formerly known as peripheral benzodiazepine receptor is a highly conserved transmembrane protein primarily located in the outer mitochondrial membrane. In the central nervous system (CNS), especially in glia cells, Tspo is upregulated upon inflammation. Consequently, Tspo was used as a tool for diagnostic imaging of neuroinflammation in the brain and as a potential
-
Pluripotent stem cell-derived models of retinal disease: Elucidating pathogenesis, evaluating novel treatments, and estimating toxicity Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-02-16 Marzena Kurzawa-Akanbi, Nikolaos Tzoumas, Julio C. Corral-Serrano, Rosellina Guarascio, David H. Steel, Michael E. Cheetham, Lyle Armstrong, Majlinda Lako
-
Modeling complex age-related eye disease Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-02-15 Silke Becker, Zia L'Ecuyer, Bryan W. Jones, Moussa A. Zouache, Fiona S. McDonnell, Frans Vinberg
Modeling complex eye diseases like age-related macular degeneration (AMD) and glaucoma poses significant challenges, since these conditions depend highly on age-related changes that occur over several decades, with many contributing factors remaining unknown. Although both diseases exhibit a relatively high heritability of >50%, a large proportion of individuals carrying AMD- or glaucoma-associated
-
Central serous chorioretinopathy: An evidence-based treatment guideline Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-02-01 Helena M.A. Feenstra, Elon H.C. van Dijk, Chui Ming Gemmy Cheung, Kyoko Ohno-Matsui, Timothy Y.Y. Lai, Hideki Koizumi, Michael Larsen, Giuseppe Querques, Susan M. Downes, Suzanne Yzer, Mark P. Breazzano, Yousif Subhi, Ramin Tadayoni, Siegfried G. Priglinger, Laurenz J.B. Pauleikhoff, Clemens A.K. Lange, Anat Loewenstein, Roselie M.H. Diederen, Reinier O. Schlingemann, Carel B. Hoyng, Jay K. Chhablani
Central serous chorioretinopathy (CSC) is a relatively common disease that causes vision loss due to macular subretinal fluid leakage and it is often associated with reduced vision-related quality of life. In CSC, the leakage of subretinal fluid through defects in the retinal pigment epithelial layer's outer blood-retina barrier appears to occur secondary to choroidal abnormalities and dysfunction
-
Phenotyping and genotyping inherited retinal diseases: Molecular genetics, clinical and imaging features, and therapeutics of macular dystrophies, cone and cone-rod dystrophies, rod-cone dystrophies, Leber congenital amaurosis, and cone dysfunction syndromes Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-01-24 Michalis Georgiou, Anthony G. Robson, Kaoru Fujinami, Thales A.C. de Guimarães, Yu Fujinami-Yokokawa, Malena Daich Varela, Nikolas Pontikos, Angelos Kalitzeos, Omar A. Mahroo, Andrew R. Webster, Michel Michaelides
Inherited retinal diseases (IRD) are a leading cause of blindness in the working age population and in children. The scope of this review is to familiarise clinicians and scientists with the current landscape of molecular genetics, clinical phenotype, retinal imaging and therapeutic prospects/completed trials in IRD. Herein we present in a comprehensive and concise manner: (i) macular dystrophies (Stargardt
-
Optic neuropathy in high myopia: Glaucoma or high myopia or both? Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-01-21 Xiulan Zhang, Jingwen Jiang, Kangjie Kong, Fei Li, Shida Chen, Peiyuan Wang, Yunhe Song, Fengbin Lin, Timothy P.H. Lin, Linda M. Zangwill, Kyoko Ohno-Matsui, Jost B. Jonas, Robert N. Weinreb, Dennis S.C. Lam, Glaucoma Suspects with High Myopia Study Group
Due to the increasing prevalence of high myopia around the world, structural and functional damages to the optic nerve in high myopia has recently attracted much attention. Evidence has shown that high myopia is related to the development of glaucomatous or glaucoma-like optic neuropathy, and that both have many common features. These similarities often pose a diagnostic challenge that will affect
-
Mechanisms of blood-retinal barrier disruption related to intraocular inflammation and malignancy Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-01-17 Oren Tomkins-Netzer, Rachael Niederer, John Greenwood, Ido Didi Fabian, Yonatan Serlin, Alon Friedman, Sue Lightman
Blood-retinal barrier (BRB) disruption is a common accompaniment of intermediate, posterior and panuveitis causing leakage into the retina and macular oedema resulting in vision loss. It is much less common in anterior uveitis or in patients with intraocular lymphoma who may have marked signs of intraocular inflammation. New drugs used for chemotherapy (cytarabine, immune checkpoint inhibitors, BRAF
-
Investing in vision: Innovation in retinal therapeutics and the influence on venture capital investment Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-01-12 Dmitrij Hristodorov, Tim Lohoff, Nanna Luneborg, Geert-Jan Mulder, Simon J. Clark
Since the groundbreaking approval of the first anti-VEGF therapy in 2004, the retinal therapeutics field has undergone a remarkable transformation, witnessing a surge in novel, disease-modifying therapeutics for a broad spectrum of retinal diseases, extending beyond exudative VEGF-driven conditions. The surge in scientific advancement and the pressing, unmet, medical need have captured the attention
-
-
Punctate inner choroidopathy: A review of the current diagnostic and therapeutic approaches Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-01-03 Dimitrios Kalogeropoulos, Najiha Rahman, Farid Afshar, Nigel Hall, Andrew John Lotery
Punctate inner choroidopathy (PIC) is an uncommon idiopathic inflammatory condition characterized by multifocal chorioretinopathy that primarily affects young adults, with a predilection for myopic females. Clinically, it manifests as small, yellowish-white lesions in the inner choroid and outer retina, often associated with inflammatory changes. Accurate diagnosis remains a challenge due to its resemblance